A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Plerixafor Impurity 10 - Request Quote

Picture of Plerixafor Impurity 10

Plerixafor Impurity 10

SZ CAT No:SZ-P070011
CAS No
NA
Mol.F.
C29H54N8
Mol.Wt.
514.8
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Plerixafor Impurity 10 is chemically 9-(4-((1,4,8,11-Tetraazacyclotetradecan-1-yl)methyl)benzyl)-2,6,9,13-tetraazabicyclo[9.3.1]pentadecane. Plerixafor Impurity 10 is supplied with detailed characterization data compliant with regulatory guideline. Plerixafor Impurity 10 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Plerixafor.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Plerixafor Impurity 10

Purchase Plerixafor Impurity 10

Plerixafor Impurity 10 suppliers

Plerixafor Impurity 10 manufacturers

Plerixafor Impurity 10 price

Order Plerixafor Impurity 10

Enquire Plerixafor Impurity 10

Plerixafor Impurity 10 cost

Plerixafor Impurity 10 Supplier

Plerixafor Impurity 10 Distributor

Plerixafor Impurity 10 for Method Validation

Plerixafor Reference Standard

Plerixafor Impurity 10 for ANDA Filing

Plerixafor Impurity 10 for Forced Degradation Studies

Plerixafor Impurity 10 Identification Standards

Plerixafor Impurity 10 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,